Literature DB >> 29222597

Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study.

Frances J Drummond1, Anna T Gavin2, Linda Sharp3.   

Abstract

PURPOSE: We investigated associations between treatment decision making (TDM) and global health-related-quality-of-life (gHRQoL) among prostate cancer (PCa) survivors.
METHODS: Postal questionnaires were sent to 6559 PCa survivors 2-18 years post-diagnosis, identified through population-based cancer registries in Ireland. The Control Preference Scale was used to investigate respondents' 'actual' and 'preferred' role in TDM. The TDM experience was considered 'congruent' when actual and preferred roles matched and 'incongruent' otherwise. The EORTC QLQ-C30 was used to measure gHRQoL. Multivariate linear regression was employed to investigate associations between (i) actual role in TDM, (ii) congruence in TDM, and gHRQoL.
RESULTS: The response rate was 54% (n = 3348). The percentages of men whose actual role in TDM was active, shared or passive were 36, 33 and 31%, respectively. Congruence between actual and preferred roles in TDM was 58%. Actual role in TDM was not associated with gHRQoL. In multivariate analysis, after adjusting for socio-demographic and clinical factors, survivors whose TDM experience was incongruent had significantly lower gHRQoL than those who had a congruent experience (- 2.25 95%CI - 4.09, - 0.42; p = 0.008). This effect was most pronounced among survivors who had more involvement in the TDM than they preferred (- 2.69 95%CI - 4.74, - 0.63; p = 0.010).
CONCLUSIONS: Less than 6 in 10 PCa survivors experienced congruence between their actual and preferred roles in TDM. Having an incongruent TDM experience was associated with lower gHRQoL among survivors. These findings suggest that involving patients in TDM to the degree to which they want to be involved may help improve PCa survivors' gHRQoL.

Entities:  

Keywords:  Adverse effects; Health-related quality of life; Prostate cancer; Survivors; Treatment; Treatment decision making

Mesh:

Year:  2017        PMID: 29222597     DOI: 10.1007/s00520-017-3994-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  43 in total

Review 1.  Decision aids for people facing health treatment or screening decisions.

Authors:  Dawn Stacey; France Légaré; Krystina Lewis; Michael J Barry; Carol L Bennett; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; Richard Thomson; Lyndal Trevena
Journal:  Cochrane Database Syst Rev       Date:  2017-04-12

2.  Treatment decision-making strategies and influences in patients with localized prostate carcinoma.

Authors:  Clement K Gwede; Julio Pow-Sang; John Seigne; Randy Heysek; Mohamed Helal; Kristin Shade; Alan Cantor; Paul B Jacobsen
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

Review 3.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

4.  Positive psychological states and coping with severe stress.

Authors:  S Folkman
Journal:  Soc Sci Med       Date:  1997-10       Impact factor: 4.634

5.  Patient participation in medical consultations: why some patients are more involved than others.

Authors:  Richard L Street; Howard S Gordon; Michael M Ward; Edward Krupat; Richard L Kravitz
Journal:  Med Care       Date:  2005-10       Impact factor: 2.983

6.  Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions.

Authors:  Elena B Elkin; Susie H M Kim; Ephraim S Casper; David W Kissane; Deborah Schrag
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

Review 7.  Patient decision aids for prostate cancer treatment: a systematic review of the literature.

Authors:  Grace A Lin; David S Aaronson; Sara J Knight; Peter R Carroll; R Adams Dudley
Journal:  CA Cancer J Clin       Date:  2009-10-19       Impact factor: 508.702

Review 8.  Current prostate cancer treatments: effect on quality of life.

Authors:  Leonard G Gomella; James Johannes; Edouard J Trabulsi
Journal:  Urology       Date:  2009-05       Impact factor: 2.649

9.  Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role.

Authors:  Thomas F Hack; Tom Pickles; J Dean Ruether; Lorna Weir; Barry D Bultz; John Mackey; Lesley F Degner
Journal:  Psychooncology       Date:  2010-06       Impact factor: 3.894

10.  Patient-reported 'ever had' and 'current' long-term physical symptoms after prostate cancer treatments.

Authors:  Anna T Gavin; Frances J Drummond; Conan Donnelly; Eamonn O'Leary; Linda Sharp; Heather R Kinnear
Journal:  BJU Int       Date:  2015-06-22       Impact factor: 5.588

View more
  4 in total

1.  Exposure to radiation and medical oncology training: A survey of Canadian urology residents and fellows.

Authors:  Amandeep S Taggar; Kevin Martell; Siraj Husain; Michael Peacock; Michael Sia; Geoffrey Gotto
Journal:  Can Urol Assoc J       Date:  2018-05-28       Impact factor: 1.862

2.  Getting the right fit: Convergence between preferred and perceived involvement in treatment decision making among medical oncology outpatients.

Authors:  Elise Mansfield; Jamie Bryant; Mariko Carey; Heidi Turon; Frans Henskens; Alice Grady
Journal:  Health Sci Rep       Date:  2018-11-06

3.  The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients.

Authors:  Andreas Ihrig; I Maatouk; H C Friederich; M Baunacke; C Groeben; R Koch; C Thomas; J Huber
Journal:  J Cancer Educ       Date:  2020-09-17       Impact factor: 1.771

4.  Patient experiences of the urgent cancer referral pathway-Can the NHS do better? Semi-structured interviews with patients with upper gastrointestinal cancer.

Authors:  Anna Haste; Mark Lambert; Linda Sharp; Richard Thomson; Sarah Sowden
Journal:  Health Expect       Date:  2020-09-28       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.